149 related articles for article (PubMed ID: 32088230)
1. DNA binding and NIR triggered DNA release from quaternary ammonium modified poly(allylamine hydrochloride) functionalized and folic acid conjugated reduced graphene oxide nanocomposites.
Roy S; Jaiswal A
Int J Biol Macromol; 2020 Jun; 153():931-941. PubMed ID: 32088230
[TBL] [Abstract][Full Text] [Related]
2. Poly(allylamine hydrochloride)-functionalized reduced graphene oxide for synergistic chemo-photothermal therapy.
Roy S; Sarkar A; Jaiswal A
Nanomedicine (Lond); 2019 Feb; 14(3):255-274. PubMed ID: 30676277
[TBL] [Abstract][Full Text] [Related]
3. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
[TBL] [Abstract][Full Text] [Related]
4. Controlled release and long-term antibacterial activity of reduced graphene oxide/quaternary ammonium salt nanocomposites prepared by non-covalent modification.
Ye X; Feng J; Zhang J; Yang X; Liao X; Shi Q; Tan S
Colloids Surf B Biointerfaces; 2017 Jan; 149():322-329. PubMed ID: 27792981
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
6. Reduced graphene oxide coated Cu
Zhen SJ; Wang TT; Liu YX; Wu ZL; Zou HY; Huang CZ
J Photochem Photobiol B; 2018 Mar; 180():9-16. PubMed ID: 29413707
[TBL] [Abstract][Full Text] [Related]
7. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
[TBL] [Abstract][Full Text] [Related]
8. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
Thapa RK; Choi Y; Jeong JH; Youn YS; Choi HG; Yong CS; Kim JO
Pharm Res; 2016 Nov; 33(11):2815-27. PubMed ID: 27573575
[TBL] [Abstract][Full Text] [Related]
9. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
Liu W; Zhang X; Zhou L; Shang L; Su Z
J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-functionalized nanographene oxide: a versatile nanocarrier for chemotherapy and photothermal therapy.
Zhang X; Nan X; Shi W; Sun Y; Su H; He Y; Liu X; Zhang Z; Ge D
Nanotechnology; 2017 Jul; 28(29):295102. PubMed ID: 28656906
[TBL] [Abstract][Full Text] [Related]
11. Heparin-reduced graphene oxide nanocomposites for curcumin delivery: in vitro, in vivo and molecular dynamics simulation study.
Shi X; Wang Y; Sun H; Chen Y; Zhang X; Xu J; Zhai G
Biomater Sci; 2019 Feb; 7(3):1011-1027. PubMed ID: 30604794
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine-doped virus-like mesoporous silica coated reduced graphene oxide nanosheets for chemo-photothermal synergetic therapy.
Liao J; Zhang H; Wang X
J Biomater Appl; 2020 Jul; 35(1):28-38. PubMed ID: 32279577
[TBL] [Abstract][Full Text] [Related]
13. The polyvinylpyrrolidone functionalized rGO/Bi2S3 nanocomposite as a near-infrared light-responsive nanovehicle for chemo-photothermal therapy of cancer.
Dou R; Du Z; Bao T; Dong X; Zheng X; Yu M; Yin W; Dong B; Yan L; Gu Z
Nanoscale; 2016 Jun; 8(22):11531-42. PubMed ID: 27203525
[TBL] [Abstract][Full Text] [Related]
14. Enhanced synergetic antibacterial activity by a reduce graphene oxide/Ag nanocomposite through the photothermal effect.
Tan S; Wu X; Xing Y; Lilak S; Wu M; Zhao JX
Colloids Surf B Biointerfaces; 2020 Jan; 185():110616. PubMed ID: 31740323
[TBL] [Abstract][Full Text] [Related]
15. Morphological Changes and Cellular Uptake of Functionalized Graphene Oxide Loaded with Protocatechuic Acid and Folic Acid in Hepatocellular Carcinoma Cancer Cell.
Buskaran K; Hussein MZ; Mohd Moklas MA; Fakurazi S
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824281
[TBL] [Abstract][Full Text] [Related]
16. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy.
Qiang L; Cai Z; Jiang W; Liu J; Tai Z; Li G; Gong C; Gao S; Gao Y
J Nanobiotechnology; 2019 Jul; 17(1):83. PubMed ID: 31291948
[TBL] [Abstract][Full Text] [Related]
17. Improved Anticancer Photothermal Therapy Using the Bystander Effect Enhanced by Antiarrhythmic Peptide Conjugated Dopamine-Modified Reduced Graphene Oxide Nanocomposite.
Yu J; Lin YH; Yang L; Huang CC; Chen L; Wang WC; Chen GW; Yan J; Sawettanun S; Lin CH
Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27860462
[TBL] [Abstract][Full Text] [Related]
18. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
Kim H; Lee D; Kim J; Kim TI; Kim WJ
ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy.
Qin XC; Guo ZY; Liu ZM; Zhang W; Wan MM; Yang BW
J Photochem Photobiol B; 2013 Mar; 120():156-62. PubMed ID: 23357205
[TBL] [Abstract][Full Text] [Related]
20. RGO/AuNR/HA-5FU nanocomposite with multi-stage release behavior and efficient antitumor activity for synergistic therapy.
Yang Y; Wang Y; Zhu M; Chen Y; Xiao Y; Shen Y; Xie A
Biomater Sci; 2017 May; 5(5):990-1000. PubMed ID: 28300268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
